Myriad Genetics MYGN
NASDAQ MYGN
$4.54 +0.48 (+11.82%)
At close: Oct 2, 2026 · 4:00 PM EDT

Myriad Genetics (MYGN) Non-Current Deffered Revenue (2015)

Updated

Myriad Genetics (MYGN) reported Non-Current Deffered Revenue of $10.45 million for Q3 2015.

Analysis

Myriad Genetics (MYGN) Non-Current Deffered Revenue (2015) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 HCA Healthcare 92.33 Bn 91.77 Bn - -
2 Natera 58.66 Bn 54.34 Bn 485.19 Mn 16.07 Mn
3 Quest Diagnostics 25.51 Bn 23.94 Bn 1.03 Bn -
4 Labcorp Holdings 24.64 Bn 22.41 Bn 1.11 Bn -
5 Guardant Health 23.35 Bn 19.41 Bn 219.03 Mn -
6 Tenet Healthcare 20.47 Bn 11.62 Bn - -
7 Tempus AI 13.40 Bn 10.43 Bn 246.50 Mn 22.08 Mn
8 Encompass Health 11.75 Bn 12.21 Bn - -
9 BrightSpring Health Services 11.31 Bn 9.65 Bn 492.75 Mn -
10 Myriad Genetics 388.14 Mn -146.46 Mn 127.00 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2015 10.45 Mn
API Access

Myriad Genetics Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=MYGN&period=max&api_key=YOUR_API_KEY